Walmsley said there is a lot of data expected in 2020. Walmsley said in the interview that the next year could see “at least six approvals of new medicines or new indications”. GSK is asking ...
NEW YORK (Reuters) - Drugmakers including Pfizer Inc <PFE.N>, GlaxoSmithKline PLC <GSK.L ... is running for re-election in 2020. Many branded drugmakers have pledged to keep their US list price ...
Sales of GSK (NYSE:GSK) and Pfizer’s (NYSE:PFE) RSV vaccines have reportedly fallen since U.S. regulators narrowed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback